Theranostics, Journal Year: 2024, Volume and Issue: 15(3), P. 1035 - 1056
Published: Dec. 11, 2024
Language: Английский
Theranostics, Journal Year: 2024, Volume and Issue: 15(3), P. 1035 - 1056
Published: Dec. 11, 2024
Language: Английский
Small, Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 16, 2024
Abstract Skin wound healing is often hindered by disrupted mitochondrial homeostasis and imbalanced macrophage glucose metabolism, posing a critical challenge to improve patient outcomes. Developing new dressings capable of effectively regulating immune‐metabolic functions remains pressing issue. Herein, highly adhesive polyethylene glycol (PEG) hydrogel loaded with the Janus kinase 1 (JAK1) inhibitor Filgotinib (Fil@GEL) prepared modulate metabolic reprogramming restore normal function. Fil@GEL exhibits superior shear adhesion strength compared commercially available tissue binder products, providing adequate for skin closure. Additionally, capacity inhibit M1‐type polarization suppressing JAK‐STAT signaling pathway, induces shift in macrophages from aerobic glycolysis oxidative phosphorylation, which results decreased lactate production, reduced reactive oxygen species (ROS) levels, restoration homeostasis. The significantly accelerates control group, reduces intra‐wound inflammation, promotes collagen regeneration. In summary, this demonstrates exceptional performance as drug carrier, exerting immunometabolic modulation through firm sustained filgotinib release, underscoring its substantial potential an effective dressing.
Language: Английский
Citations
3Theranostics, Journal Year: 2024, Volume and Issue: 15(3), P. 1035 - 1056
Published: Dec. 11, 2024
Language: Английский
Citations
1